NEW YORK (GenomeWeb News) — Sequenom today said that New York State health officials have approved a noninvasive prenatal test based on the firm’s SEQureDx technology for cell-free fetal nucleic-acid assessment.
 
The lab-developed test, performed on a real-time PCR platform, is designed to detect Rhesus D incompatibility. It will be marketed by Lenetix Medical Screening Laboratory, Sequenom’s CLIA-certified, nonexclusive licensee.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.